NCT00652288View on ClinicalTrials.gov

Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Diabetes Mellitus, Type I
Interventions
DRUG

Insulin analogs (Lispro and Aspart)

Insulin bolus given through insulin pump

DRUG

Insulin analogs (Aspart and Detemir)

Drugs given separately

DRUG

Insulin analogs (Aspart and Detemir)

Drugs given in the same injection

DRUG

Insulin analogs (Lispro and Glargine)

Drugs given separately

DRUG

Insulin analogs (Lispro and Glargine)

Drugs given in single injection

All Listed Sponsors
lead

Yale University

OTHER

NCT00652288 - Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs | Biotech Hunter | Biotech Hunter